abstract |
The present invention relates to the use of a compound of formula I, preferably 4-[3, 5-bis (2-hydroxyphenyl)-[1,2,4]triazol-1-yl] benzoic acid or a pharmaceutically acceptable salt thereof for the preparation of a medicament for use in the treatment of biofilm formation, e.g. of P. aeruginosa, e.g. in cystic fibrosis patients. |